Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission

被引：15
作者：
Giuliano, M
Palmisano, L
Galluzzo, CM
Amici, R
Germinario, E
Okong, P
Kituuka, P
Mmirro, F
Magoni, M
Vella, S
机构：
[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
[2] St Francis Nsambya Hosp, Kampala, Uganda
[3] Mulago Hosp, Kampala, Uganda
来源：
AIDS | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1097/00002030-200307040-00022
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Two zidovudine/lamivudine regimens for the prevention of HIV perinatal transmission were studied for the selection of resistance mutations. The M184V mutation was detected one week after delivery in six out of fifty women (12%) who received the regimen prepartum, intrapartum and postpartum, and was no longer present 3 months later. No nucleoside reverse transcriptase inhibitor resistance-associated mutations were detected in 50 women who received zidovudine/lamivudine intrapartum and postpartum only. No association with the risk of perinatal transmission was found.
引用
收藏
页码：1570 / 1572
页数：3
相关论文
共 50 条
[31]   Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand [J].
Briand, Nelly ;
Pornprosert, Sakorn ;
Ngo-Giang-Huong, Nicole ;
Galacteros, Frederic ;
Pissard, Serge ;
Tatu, Thanusak ;
Sanguansermsri, Torpong ;
Jourdain, Gonzague ;
Lallemant, Marc ;
Le Coeur, Sophie .
ANTIVIRAL THERAPY, 2009, 14 (01) :117-122
[32]   Preventing perinatal HIV transmission: Zidovudine use during pregnancy [J].
Carmichael, C .
AMERICAN FAMILY PHYSICIAN, 1997, 55 (01) :171-174
[33]   Zidovudine in HIV-positive pregnant women and their babies [J].
Samuel, NM ;
Kumari, S .
NATIONAL MEDICAL JOURNAL OF INDIA, 1996, 9 (04) :200-201
[34]   Trends in zidovudine prescription for pregnant women infected with HIV [J].
Lansky, A ;
Jones, JL ;
Wan, PCT ;
Lindegren, ML ;
Wortley, P .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 (03) :289-292
[35]   Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy [J].
Kuritzkes, DR ;
Shugarts, D ;
Bakhtiari, M ;
Poticha, D ;
Johnson, J ;
Rubin, M ;
Gingeras, TR ;
Kennedy, M ;
Eron, JJ .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (01) :26-34
[36]   The value of contraception to prevent perinatal HIV transmission [J].
Reynolds, Heidi W. ;
Janowitz, Barbara ;
Homan, Rick ;
Johnson, Laura .
SEXUALLY TRANSMITTED DISEASES, 2006, 33 (06) :350-356
[37]   Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir [J].
Descamps, D ;
Flandre, P ;
Joly, V ;
Meiffrédy, V ;
Peytavin, G ;
Izopet, J ;
Tamalet, C ;
Zeng, AF ;
Harel, T ;
Lastère, S ;
Aboulker, JP ;
Yéni, P ;
Brun-Vézinet, F .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (05) :464-471
[38]   Treat pregnant HIV positive women earlier to prevent transmission, says WHO [J].
Zarocostas, John .
BRITISH MEDICAL JOURNAL, 2009, 339
[39]   Lack of resistant mutation development after receiving short-course zidovudine plus lamivudine to prevent mother-to-child transmission [J].
Chokephaibulkit, K ;
Chaisilwattana, P ;
Vanprapar, N ;
Phongsamart, W ;
Sutthen, R .
AIDS, 2005, 19 (11) :1231-1233
[40]   Perinatal HIV Service Coordination: Closing Gaps in the HIV Care Continuum for Pregnant Women and Eliminating Perinatal HIV Transmission in the United States [J].
Andrews, Mary-Margaret ;
Storm, Deborah S. ;
Burr, Carolyn K. ;
Aaron, Erika ;
Hoyt, Mary Jo ;
Statton, Anne ;
Weber, Shannon .
PUBLIC HEALTH REPORTS, 2018, 133 (05) :532-542
12345